Torsades de pointes risk factors: Difference between revisions
Created page with "__NOTOC__ {{Torsades de pointes}} {{CMG}} ==Overview== ==Risk Factors== Factors that are associated with an increased tendency toward torsades de pointes include: * [[Famil..." |
|||
(7 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Long QT syndrome]] is a risk factor for developing torsades de pointes, and can either be inherited as congenital mutations of ion channels carrying the cardiac impulse/action potential, or acquired as a result of drugs that block these cardiac ion currents. Other risk factors include [[electrolyte abnormalities]], [[heart failure]], [[left ventricular hypertrophy]], female gender or renal and [[liver failure]]. Being on certain medications also pose a risk for developing torsades de pointes. | |||
==Risk Factors== | ==Risk Factors== | ||
Factors that are associated with an increased tendency toward torsades de pointes include: | Factors that are associated with an increased tendency toward torsades de pointes include: | ||
Line 18: | Line 20: | ||
* [[Female|Female gender]] | * [[Female|Female gender]] | ||
* Baseline electrocardiographic abnormalities | * Baseline electrocardiographic abnormalities | ||
* Renal or liver failure | * [[Renal failure]] or [[liver failure]] | ||
===Clinical Correlation === | |||
# Drugs: [[quinidine]], [[PCA]], [[norpace]], [[amiodarone]], [[phenothiazines]], [[tricyclic antidepressants]], [[pentamidine]]. | |||
#* with [[quinidine]] majority of the cases occur within one week of initiation, and with therapeutic levels | |||
# Electrolyte imbalances: [[hypokalemia]], [[hypomagnesemia]], [[hypocalcemia]] | |||
# [[CAD]] | |||
# [[MVP]] | |||
# Variant [[angina]] | |||
# [[Myocarditis]] | |||
# [[Subarachnoid hemorrhage]] | |||
# Congenital QT prolongation | |||
# Liquid protein diets | |||
# [[Hypothyroidism]] | |||
#* because of bradycardia and a prolonged QT syndrome | |||
# Organophosphate poisoning <ref>Chou's Electrocardiography in Clinical Practice Third Edition, pp. 398-409.</ref> <ref>Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:194 ISBN 1591032016</ref> | |||
==References== | ==References== |
Latest revision as of 16:10, 18 October 2012
Torsades de pointes Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Torsades de pointes risk factors On the Web |
American Roentgen Ray Society Images of Torsades de pointes risk factors |
Risk calculators and risk factors for Torsades de pointes risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Long QT syndrome is a risk factor for developing torsades de pointes, and can either be inherited as congenital mutations of ion channels carrying the cardiac impulse/action potential, or acquired as a result of drugs that block these cardiac ion currents. Other risk factors include electrolyte abnormalities, heart failure, left ventricular hypertrophy, female gender or renal and liver failure. Being on certain medications also pose a risk for developing torsades de pointes.
Risk Factors
Factors that are associated with an increased tendency toward torsades de pointes include:
- Familial long QT syndrome
- Class IA antiarrhythmics
- Hypomagnesemia
- Hypokalemia
- Hypoxia
- Acidosis
- Heart failure
- Left ventricular hypertrophy
- Slow heart rate
- Female gender
- Baseline electrocardiographic abnormalities
- Renal failure or liver failure
Clinical Correlation
- Drugs: quinidine, PCA, norpace, amiodarone, phenothiazines, tricyclic antidepressants, pentamidine.
- with quinidine majority of the cases occur within one week of initiation, and with therapeutic levels
- Electrolyte imbalances: hypokalemia, hypomagnesemia, hypocalcemia
- CAD
- MVP
- Variant angina
- Myocarditis
- Subarachnoid hemorrhage
- Congenital QT prolongation
- Liquid protein diets
- Hypothyroidism
- because of bradycardia and a prolonged QT syndrome
- Organophosphate poisoning [1] [2]